The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (CE) alone or in combination with nivolumab as frontline therapy for extensive-stage small cell lung cancer (ES-SCLC): ECOG-ACRIN EA5161.
Ticiana Leal
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech; Genentech; InvisionFirst Lung; Merck; Merck; Novocure; Takeda; Takeda
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Genentech; Merck; Mirati Therapeutics; Mirati Therapeutics; Mirati Therapeutics; Takeda; Takeda
Yating Wang
No Relationships to Disclose
Afshin Dowlati
Consulting or Advisory Role - Abbvie/Stemcentrx; AstraZeneca; Bristol-Myers Squibb; Seagen; Takeda
Research Funding - Abbvie/Stemcentrx (Inst); Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ipsen (Inst); Lilly/ImClone (Inst); Mirati Therapeutics (Inst); Regeneron (Inst); Seagen (Inst); Symphogen (Inst); Takeda (Inst); Tesaro (Inst); United Therapeutics (Inst)
DeQuincy Andrew Lewis
No Relationships to Disclose
Yuanbin Chen
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genentech; Pfizer; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Guardant Health; Lilly; Merck; Novartis; Roche/Genentech; Takeda
Research Funding - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Helsinn Therapeutics; Ipsen; Roche/Genentech
Expert Testimony - AstraZeneca; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Ipsen
Amit Ramesh Mohindra
No Relationships to Disclose
Mohammad Razaq
Stock and Other Ownership Interests - Abbvie (I); Cerus (I); Merck
Consulting or Advisory Role - Aspyrian Therapeutics; AstraZeneca
Speakers' Bureau - Merck
Harish G. Ahuja
No Relationships to Disclose
Jijun Liu
Employment - illinois Cancer Care
Speakers' Bureau - Genentech
Travel, Accommodations, Expenses - Genentech
David M. King
No Relationships to Disclose
Christopher Joseph Sumey
Consulting or Advisory Role - Bristol-Myers Squibb
Suresh S. Ramalingam
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Loxo; Merck; Nektar; Takeda; Tesaro
Research Funding - Abbvie (Inst); Advaxis (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genmab (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - AstraZeneca